AbstractRelative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the interpretation of vaccine efficacy. The present article uses clinical epidemiologic … Continue reading Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials – NCBI